Phase 0
Microdosing
Microdialysis
Phase I
First-in-Human
Single Ascending Dose (SAD)
Multiple Ascending Dose (MAD)
Pharmakokinetics/Pharmacodynamics (PK/PD)
Bioavailability
Bioequivalence
Drug-drug Interaction (DDI)
Food Interaction
ADME Studies
Healthy Volunteers and Patients
Phase II
Proof-of-Concept, Efficacy or Mechanism
Dose Finding
Multi-centre
Late Phase
Site Management Organisation (SMO)
Site Network
Medical Device
Pilot/First-in-Human
Early and Traditional Feasibility
User Testing
Functional Food
Nicotine Based Products
Advanced Therapeutic Medicinal Products (ATMP)
Non-Interventional Studies
